| Literature DB >> 30581134 |
Khuchtumur Bum-Erdene1, Donghui Zhou1, Giovanni Gonzalez-Gutierrez2, Mona K Ghozayel1, Yubing Si1, David Xu3, Harlan E Shannon4, Barbara J Bailey4, Timothy W Corson5, Karen E Pollok4, Clark D Wells1, Samy O Meroueh6.
Abstract
The Hippo pathway coordinates extracellular signals onto the control of tissue homeostasis and organ size. Hippo signaling primarily regulates the ability of Yap1 to bind and co-activate TEA domain (TEAD) transcription factors. Yap1 tightly binds to TEAD4 via a large flat interface, making the development of small-molecule orthosteric inhibitors highly challenging. Here, we report small-molecule TEAD⋅Yap inhibitors that rapidly and selectively form a covalent bond with a conserved cysteine located within the unique deep hydrophobic palmitate-binding pocket of TEADs. Inhibition of TEAD4 binding to Yap1 by these compounds was irreversible and occurred on a longer time scale. In mammalian cells, the compounds formed a covalent complex with TEAD4, inhibited its binding to Yap1, blocked its transcriptional activity, and suppressed expression of connective tissue growth factor. The compounds inhibited cell viability of patient-derived glioblastoma spheroids, making them suitable as chemical probes to explore Hippo signaling in cancer.Entities:
Keywords: Hippo signaling; TEAD transcription factor; Yap co-activator; allosteric inhibitors; covalent inhibitors; protein-protein interaction inhibitors; small-molecule inhibitors
Mesh:
Substances:
Year: 2018 PMID: 30581134 DOI: 10.1016/j.chembiol.2018.11.010
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116